Cargando…
Nivolumab-related myasthenia gravis with myositis requiring prolonged mechanical ventilation: a case report
BACKGROUND: Nivolumab is an immune checkpoint inhibitor that blocks inhibitors of T-cell activation and blunts antitumor immunity and is used in the treatment of various cancers. However, immune checkpoint inhibitors have immune-related adverse effects on various organs due to promoting T-cell activ...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842808/ https://www.ncbi.nlm.nih.gov/pubmed/35152911 http://dx.doi.org/10.1186/s13256-022-03286-x |